Craneware (LON:CRW)‘s stock had its “buy” rating reiterated by Peel Hunt in a research report issued on Tuesday. They currently have a GBX 2,100 ($29.01) price target on the stock. Peel Hunt’s target price suggests a potential upside of 25.00% from the company’s current price.

Shares of Craneware (LON:CRW) opened at GBX 1,680 ($23.21) on Tuesday. Craneware has a fifty-two week low of GBX 1,165 ($16.10) and a fifty-two week high of GBX 1,905 ($26.32). The firm has a market capitalization of $427.06 and a price-to-earnings ratio of 4,800.00.

WARNING: This piece was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright legislation. The original version of this piece can be read at

About Craneware

Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention.

Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with's FREE daily email newsletter.